The table below shows ANI PHARMACEUTICALS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$58.38M
$34.99M
$18.27M
$21.42M
-$18.94M
$20.67M
Capital expenditure
$6.07M
$2.47M
$4.58M
$2.35M
$1.95M
$698.00K
Investing cash flow
-$11.32M
-$19.85M
$8.93M
-$2.35M
-$2.18M
-$737.00K
Dividends paid
$0.00
$406.00K
$406.00K
$406.00K
ANIP operating cash flow (10-K history)
ANI PHARMACEUTICALS INC reported operating cash flow of $185.22M for fiscal year 2025. That is up 189.3% from $64.02M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $27.47M (FY 2016) to $185.22M. Figures come from the company's audited annual reports as filed with the SEC.